Amputations for extremity soft tissue sarcoma in an era of limb salvage treatment: Local control and survival
- 16 October 2017
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (3) , 434-442
Abstract
Background: Despite multimodality limb salvage treatment (LST) for locally advanced extremity soft tissue sarcoma (ESTS), some patients still need an amputation. Indications for amputation and oncological outcome for these patients are described.Methods: Between 1996 and 2016, all patients who underwent an amputation for ESTS were included. Patients who underwent an amputation as primary or as non‐primary treatment formed Group I and II, respectively.Results: Thirty‐nine patients were included, 16 in Group I (41%) and 23 in Group II (59%). Tumor size or local recurrence which could not be treated with LST were the two main reasons for amputation. Local recurrence free survival (LRFS) (P = 0.396), distant metastases free survival (DMFS) (P = 0.965), disease‐specific survival (DSS) (P = 0.745), and overall survival (OS) (P = 0.718) were comparable for both groups. Ten‐year LRFS was 90.0% versus 83.7%; DMFS was 31.0% versus 42.2%; DSS was 52.2% versus 44.1%; and OS was 44.2% versus 41.6%, for group I and II respectively.Conclusions: Oncological outcome seems to be comparable between patients who underwent a primary or a non‐primary amputation for ESTS. With the on‐going possibilities concerning prosthesis and rehabilitation programs, it remains important to decide in a multidisciplinary sarcoma team meeting which treatment suits best for each individual patient.Keywords
Funding Information
- Stichting MelanomaSarcomaGroningana (Ubbergseveldweg 144, Nijmegen, The Netherlands)
This publication has 30 references indexed in Scilit:
- Radiotherapy for Management of Extremity Soft Tissue Sarcomas: Why, When, and Where?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long‐term patient outcomeJournal of Surgical Oncology, 2011
- Proximal major limb amputations – a retrospective analysis of 45 oncological casesWorld Journal of Surgical Oncology, 2009
- Barriers to rehabilitation of patients with extremity sarcomasJournal of Surgical Oncology, 2007
- Quality of Life After Hyperthermic Isolated Limb Perfusion for Locally Advanced Extremity Soft Tissue SarcomaAnnals of Surgical Oncology, 2006
- The Indications for and the Prognostic Significance of Amputation as the Primary Surgical Procedure for Localized Soft Tissue Sarcoma of the ExtremityAnnals of Surgical Oncology, 2004
- Major amputation for soft-tissue sarcomaBritish Journal of Surgery, 2003
- Amputation for Recurrent Soft Tissue Sarcoma of the Extremity: Indications and OutcomeAnnals of Surgical Oncology, 2001
- Quality of Life Implications as a Consequence of Surgery: Limb Salvage, Primary and Secondary AmputationSarcoma, 2001
- The Treatment of Soft-tissue Sarcomas of the ExtremitiesAnnals of Surgery, 1982